Truist Financial Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Announces Target Price $1,200
Truist Financial analyst Robyn Karnauskas maintains $Regeneron Pharmaceuticals(REGN.US)$ with a buy rating, and sets the target price at $1,200.According to TipRanks data, the analyst has a success
Regeneron Stock Slides After Court Rejects Injunction Against Eye Drug Biosimilar, Truist Says
Overweight Quality Stocks With Positive EPS Revision - MS
Express News | Wells Fargo & Co maintains the target price of Regeneron Pharmaceuticals at $1200.00.
4D Molecular Therapeutics Downgraded at Cantor Following Wet AMD Asset Data
Wells Fargo Reiterates Overweight on Regeneron Pharmaceuticals, Maintains $1200 Price Target
Smart Money Is Betting Big In REGN Options
Regeneron Falls After Judge Denies Motion for Injunction in a Patent Case With Amgen
Regeneron Pharmaceuticals on Track for Largest Percent Decrease Since June 2023 -- Data Talk
Regeneron, Sanofi Say Eosinophilic Esophagitis Drug Recommended for Children in EU
Express News | Dupixent® (Dupilumab) Recommended for EU Approval by the Chmp to Treat Eosinophilic Esophagitis (Eoe) in Children as Young as 1 Year Old
The Best Biotech Plays Outside the GLP-1 Weight-loss Market
Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.
Prepare yourself for the interest rate cut cycle.
Regeneron Pharma Price Target Maintained With a $1282.00/Share by RBC Capital
RBC Capital Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,282
RBC Capital analyst Brian Abrahams maintains $Regeneron Pharmaceuticals(REGN.US)$ with a buy rating, and maintains the target price at $1,282.According to TipRanks data, the analyst has a success
BMO Capital Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,300
BMO Capital analyst Evan Seigerman maintains $Regeneron Pharmaceuticals(REGN.US)$ with a buy rating, and maintains the target price at $1,300.According to TipRanks data, the analyst has a success
BofA Securities Initiates Regeneron Pharmaceuticals(REGN.US) With Sell Rating, Announces Target Price $805
BofA Securities analyst Alec Stranahan initiates coverage on $Regeneron Pharmaceuticals(REGN.US)$ with a sell rating, and sets the target price at $805.According to TipRanks data, the analyst has a
Cantor Fitzgerald Reiterates Neutral on Regeneron Pharmaceuticals, Maintains $1015 Price Target
Regeneron Pharmaceuticals Analyst Ratings
Don't just focus on the polls! The trend of the US stock market is the compass for the US presidential election. Here is an investment guide for you to check out.
Analysts have found that since 1984, as long as the S&P 500 index rises accumulatively between August and October, the ruling party will win the election; on the contrary, if the S&P 500 index drops during this period, the challenger will win.